By continuing to use this website, you agree to our Cookies Policy

ACCEPT

Trending Activities
Respiratory, Allergy
touchPANEL DISCUSSION
Strategies for the management of chronic rhinosinusitis with nasal polyps: Expert insight in optimizing care
Prof. Claire Hopkins, Prof. Claus Bachert, Prof. Martin Desrosiers Available in:
Watch Time: 44 mins

Watch a panel of experts discuss challenges in the diagnosis of CRSwNP and considerations for optimal management of the disease.

Learning objectives
Learning Objectives
  • Define diagnostic criteria for CRSwNP
  • Recognize that eosinophilic inflammation in CRSwNP is a predictor of disease recurrence
  • Outline advancements in the treatment of CRSwNP

Curriculum Activities

Learn more with a series of activities which are linked and developed as a curriculum

Allergy , Asthma , Respiratory Tract Disorders
touchCURRICULUM
Eosinophilic inflammatory disease
 Dr Enrico Heffler (Italy), Dr Harissios Vliagoftis (Canada), Prof. Ian Pavord (UK), Prof. Alberto Papi (Italy), Prof. Claire Hopkins (UK), Prof. Claus Bachert (Belgium), Prof. Martin Desrosiers (Canada)

Watch interviews and expert perspectives covering the latest developments in the management of eosinophilic inflammatory disease.

Allergy , Asthma , Respiratory Tract Disorders
Curriculum Inclusions:
  • Describe the role of eosinophilis in physiologic homeostasis and in the pathophysiology of disease
  • Discuss the role of interleukin (IL)-5 in the pathogenesis of eosinophilic diseases such as severe eosinophilic asthma, hypereosinophilic syndromes and eosinophilic granulomatosis with polyangiitis
  • Identify patients with eosinophilic diseases such as severe eosinophilic asthma, hypereosinophilic syndromes, eosinophilic granulomatosis with polyangiitis and chronic rhinosinusitis with nasal polyps

All Activities

View all Education activities

Respiratory, Allergy
touchPANEL DISCUSSION
Strategies for the management of chronic rhinosinusitis with nasal polyps: Expert insight in optimizing care
Prof. Claire Hopkins, Prof. Claus Bachert, Prof. Martin Desrosiers Available in:

Watch a panel of experts discuss challenges in the diagnosis of CRSwNP and considerations for optimal management of the disease.

Learning objectives
Learning Objectives
  • Define diagnostic criteria for CRSwNP
  • Recognize that eosinophilic inflammation in CRSwNP is a predictor of disease recurrence
  • Outline advancements in the treatment of CRSwNP
Respiratory, Immunology
touchPANEL DISCUSSION
Eosinophilic inflammatory diseases of the respiratory system: New therapeutic options
Dr Harissios Vliagoftis, Prof. Ian Pavord, Prof. Alberto Papi Available in:

Watch a panel of experts discuss how to identify and manage patients with inflammatory respiratory diseases, with a focus on severe eosinophilic asthma.

Learning objectives
Learning Objectives
  • Recognize the role of eosinophils and type 2 inflammation in respiratory disease
  • Understand the diagnostic methods used to differentiate inflammatory diseases of the respiratory system
  • Recall disease states that may benefit from therapies that target the complex interaction between eosinophils and their environment
Axial Spondyloarthritis
touchTALKS
Women with axSpA: Navigating the childbearing years
Prof. Peter C Taylor

Join Prof. Peter C Taylor as he discusses the unique challenges that women with axSpA face on their journey to motherhood.

Learning objectives
Learning Objectives
  • Recognize that prevalence, diagnosis, disease progression and treatment efficacy differ between men and women with axSpA
  • Evaluate the unique challenges that exist for women of childbearing age with axSpA
  • Discuss optimal treatment strategies for women of childbearing age with axSpA
Respiratory, Allergy, Immunology
touchTALKS
The role of eosinophils in physiology and disease: Is complete depletion of eosinophils the goal?
Dr Enrico Heffler Available in:

Watch Dr Enrico Heffler describe how eosinophilic inflammation can be targeted for the treatment of inflammatory respiratory diseases.

Learning objectives
Learning Objectives
  • Understand the dynamics of eosinophils across the human body in wellness and disease
  • Discuss clinical scenarios in which eosinophilic therapy may be beneficial
  • Recognize how new eosinophilic therapies offer promise for the future treatment of eosinophil-mediated diseases
IME
Education activities are developed by touchIME for touchIMMUNOLOGY.

Our education resources are developed in collaboration with our well established peer-reviewed medical journals, our Editorial Board members and partnerships with major medical societies, with a clear commitment to high-quality independent education.

Copied to clipboard!
accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Sponsored Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72